openPR Logo
Press release

Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017

05-11-2017 10:41 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Natural Killer Cells Therapies- Competitive Landscape,

DelveInsight Report, “Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell products in research and development.

The Report covers 20+ companies, which are active in this field with 40+ products and many different technologies. This report covers NK cell-based therapies along with drugs that augment (enhance or activate) the NK cells. The Report provides in-depth analysis of the Natural Killer Cell-based therapies profiles along with the augmenting therapies covering their pre-clinical and clinical studies, collaborations details and deal values, Technologies and Targeted antigens. The Report provides the NK Cell-based therapies licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis.

Reports Highlights:

NK cell Therapy Pipeline scenario which includes NK cell therapies and NK cell augmenting therapies.

Collaborations & partnering deals

Current Prominent Research Areas and Key Players

Pipeline product profiles NK Cell therapy Technologies and NK cell Augmenting Therapies

Licensing opportunities

Market Drivers and Barriers

Scope

Overview of the global NK cell therapy pipeline scenario, products, and associated companies information

Coverage of global NK cell therapies and drugs that enhance the activity of NK under development

Competitive landscape of products for key players and related indications

Coverage of licensors, collaborators and development partners, deal terms and deal values estimation

Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities

Highlights of licensing & collaboration opportunities and funding details

Highlights of latest NK cell therapy technologies and NK cell augmenting therapies and innovative companies

Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

To know more please click this link https://www.delveinsight.com/natural-killer-cells-therapies-competitive-landscape-technology-and-pipeline-analysis-2017-11092-p.php

DelveInsight is a Business Consultant company and serves as a Knowledge partner across the value chain of Pharmaceutical Industry. With the use of proprietary databases and analytical models, DelveInsight provides cutting-edge market and pipeline analysis and API intelligence across all therapy areas to the Pharma and biotech sector, helping clients to quantify market events and evaluate their impact on the valuation of products, portfolios, and companies.

DelveInsight business research,

A20, Sector 7, Near to Maxfort. School, Dwarka

New Delhi-110077, India

Tel: +91-11-4568 9769 | +91 9650213330

Email: info@delveinsight.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017 here

News-ID: 532223 • Views:

More Releases from DelveInsight Business Research

The Global Powered Surgical Instruments Market to Register Growth at a Stunning CAGR of 4.26% by 2030, Assess DelveInsight | Stryker, CONMED Corporation, Medtronic, DePuy Synthes (Medical Devices Business Services), MicroAire Surgical Instruments, Zimmer
The Global Powered Surgical Instruments Market to Register Growth at a Stunning …
(Albany, USA) As per DelveInsight analysis, the Powered Surgical Instruments market is growing positively due to the factors such as an increase in geriatric population, having a high prevalence of bone disorders and ophthalmic conditions, and along with the increasing incidence of brain cancers as well increase in the number of trauma cases, and a parallel growth in product innovation. DelveInsight's Powered Surgical Instruments Market Insights report provides the current and
The Global Glaucoma Drainage Devices Market to Register Growth at a Stunning CAGR of 11.95% by 2030 | DelveInsight
The Global Glaucoma Drainage Devices Market to Register Growth at a Stunning CAG …
The glaucoma drainage devices market is anticipated to boost owing to the rising prevalence of glaucoma diseases, the rising geriatric population susceptible to glaucoma, the rising adoption of surgical treatments for glaucoma, among others. DelveInsight's Glaucoma Drainage Devices Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies' market shares, challenges, glaucoma drainage devices market drivers, barriers, and trends, and key glaucoma drainage devices companies in
Diffuse Large B-cell Lymphoma Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies, ROA, MOA and Key Companies involved by DelveInsight | Genmab, Roche, Acerta Pharma, Autolus, Xynomic Pharmaceuticals, Genentech, Celgene, AbbVie, Mabion, Ph
Diffuse Large B-cell Lymphoma Pipeline Assessment 2024: Clinical Trials, FDA App …
As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in the Diffuse Large B-cell Lymphoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years. "Diffuse Large B-cell Lymphoma (DLBCL) Pipeline Insight, 2024" report by
Esophageal Squamous Cell Carcinoma Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies, ROA, MOA and Key Companies involved by DelveInsight | BeiGene, AstraZeneca, Servier, Hoffmann-La Roche, Eli Lilly, Ipsen, Shire, GlaxoSmithKline, Novar
Esophageal Squamous Cell Carcinoma Pipeline Assessment 2024: Clinical Trials, FD …
(Albany, USA) DelveInsight's, "Esophageal Squamous Cell Carcinoma Pipeline Insight" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Esophageal Squamous Cell Carcinoma pipeline landscape. It covers the Esophageal Squamous Cell Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key

All 5 Releases


More Releases for Cell

Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Load Cell Market Key Player Analysis By Single Point Load Cell, Compression Load …
The Load Cell Report consists of all the basic information regarding the Load Cell market. The all-inclusive report will aid users to understand the market current trends, industry growth drivers, share, analysis, size, production, forecast trends, supply, sales, demands, and many other aspects. The analysis was accomplished using an objective amalgamation of primary and secondary data including contributions from major participants in the market. The global Load Cell report is
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports. In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem …
Researchmoz added Most up-to-date research on "Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem Cell Culture, Neural Stem Cell Culture & Mesenchymal Stem Cell Culture" to its huge collection of research reports. In this report, the global Stem Cell Media market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a